Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01373671 · ClinicalTrials.gov registry record · NA
Evaluation of the Efficacy of Digital Breast Tomosynthesis Imaging
A NA study of Breast Cancer, sponsored by Siemens Medical Solutions USA - CSG.
- Completed
- Registry status
- NA
- Development phase
- 764
- Enrollment target
- 1
- Study location
NCT01373671: Completed NA study of Breast Cancer, sponsored by Siemens Medical Solutions USA - CSG.
NCT01373671 is a NA study of Breast Cancer that has completed, run by Siemens Medical Solutions USA - CSG. The registered enrollment target is 764 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01373671, a NA study of Breast Cancer, has completed, sponsored by Siemens Medical Solutions USA - CSG.
- COMPLETED
- Registry status
- NA
- Development phase
- 764 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this protocol is to collect the 2-dimensional (2D) screening and diagnostic images, and 3-dimensional (3D) Digital Breast Tomosynthesis (DBT) scans from patient mammography examinations acquired on various commercially available Full Field Digital Mammography (FFDM) systems and the Siemens Inspiration DBT system, respectively.
Conditions Studied
Interventions
- DEVICE SIEMENS INSPIRATION DIGITAL BREAST TOMOSYNTHESIS (DBT) SYSTEM
Study Locations (1)
Pennsylvania
- Siemens Medical Solutions - Malvern
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 764 participants |
| Start Date | 2011-05 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01373671
The ClinicalTrials.gov registry entry for NCT01373671 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 764 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (73% lower). The listed sponsor is Siemens Medical Solutions USA - CSG, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which SIEMENS INSPIRATION DIGITAL BREAST TOMOSYNTHESIS (DBT) SYSTEM is the first listed.
NCT01373671 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01373671 about?
NCT01373671 is a clinical study titled "Evaluation of the Efficacy of Digital Breast Tomosynthesis Imaging". The primary objective of this protocol is to collect the 2-dimensional (2D) screening and diagnostic images, and 3-dimensional (3D) Digital Breast Tomosynthesis (DBT) scans from patient mammography examinations acquired on various commercially available Full Field Digital Mammography (FFDM) systems ...
What is the current status of trial NCT01373671?
This trial is currently completed. It is a NA study. The enrollment target is 764 participants. The study started on 2011-05. Estimated completion is 2014-05.
What conditions does trial NCT01373671 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01373671?
The interventions under investigation include: SIEMENS INSPIRATION DIGITAL BREAST TOMOSYNTHESIS (DBT) SYSTEM (DEVICE).
Who is sponsoring clinical trial NCT01373671?
This trial is sponsored by Siemens Medical Solutions USA - CSG, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01373671 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.